Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08JSR
|
||||
Former ID |
DNC003551
|
||||
Drug Name |
Tetrahydro-pyrimidin-2-ylideneamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C4H9N3
|
||||
Canonical SMILES |
C1CNC(=NC1)N
|
||||
InChI |
1S/C4H9N3/c5-4-6-2-1-3-7-4/h1-3H2,(H3,5,6,7)
|
||||
InChIKey |
PEHDFSFYZKSKGH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Nitric-oxide synthase, brain | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
KEGG Pathway | Arginine and proline metabolism | ||||
Metabolic pathways | |||||
Calcium signaling pathway | |||||
Phagosome | |||||
Circadian entrainment | |||||
Long-term depression | |||||
Salivary secretion | |||||
Alzheimer's disease | |||||
Amyotrophic lateral sclerosis (ALS) | |||||
NetPath Pathway | EGFR1 Signaling Pathway | ||||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Arginine and Proline Metabolism | ||||
Reactome | ROS production in response to bacteria | ||||
Nitric oxide stimulates guanylate cyclase | |||||
WikiPathways | Monoamine Transport | ||||
Myometrial Relaxation and Contraction Pathways | |||||
Amyotrophic lateral sclerosis (ALS) | |||||
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | |||||
Spinal Cord Injury | |||||
Alzheimers Disease | |||||
Effects of Nitric Oxide | |||||
Serotonin Transporter Activity | |||||
References | |||||
REF 1 | J Med Chem. 1996 Feb 2;39(3):669-72.2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.